Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001297184-25-000008
Filing Date
2025-03-03
Accepted
2025-03-03 16:16:15
Documents
122
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amph-20241231x10k.htm   iXBRL 10-K 4211971
2 EX-19.1 amph-20241231xex19d1.htm EX-19.1 89066
3 EX-21.1 amph-20241231xex21d1.htm EX-21.1 16076
4 EX-23.1 amph-20241231xex23d1.htm EX-23.1 13539
5 EX-31.1 amph-20241231xex31d1.htm EX-31.1 19460
6 EX-31.2 amph-20241231xex31d2.htm EX-31.2 18993
7 EX-32.1 amph-20241231xex32d1.htm EX-32.1 9067
8 EX-32.2 amph-20241231xex32d2.htm EX-32.2 9241
9 GRAPHIC amph-20241231x10k001.jpg GRAPHIC 72533
  Complete submission text file 0001297184-25-000008.txt   17266566

Data Files

Seq Description Document Type Size
10 EX-101.SCH amph-20241231.xsd EX-101.SCH 94882
11 EX-101.CAL amph-20241231_cal.xml EX-101.CAL 121375
12 EX-101.DEF amph-20241231_def.xml EX-101.DEF 398460
13 EX-101.LAB amph-20241231_lab.xml EX-101.LAB 757802
14 EX-101.PRE amph-20241231_pre.xml EX-101.PRE 687705
125 EXTRACTED XBRL INSTANCE DOCUMENT amph-20241231x10k_htm.xml XML 3370478
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36509 | Film No.: 25698138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)